Global Biological Defense 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI12241531

Publication Date:

December 4, 2024

Pages:

127

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Biological Defense market size was valued at US$ 1119.1 million in 2023. With growing demand in downstream market, the Biological Defense is forecast to a readjusted size of US$ 1426.4 million by 2030 with a CAGR of 3.5% during review period.
The research report highlights the growth potential of the global Biological Defense market. Biological Defense are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Biological Defense. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Biological Defense market.
Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.

In the wake of the 2001 anthrax attacks, the U.S. government set out on a bold path to improve the country鈥檚 preparedness for bioterrorism by developing and stockpiling new drugs and vaccines to protect Americans from health emergencies. Since 2004, the US government has provided assistance in the development and manufacturing of products in order to maintain its Strategic National Stockpile (SNS) to counter any bioterror attack.
The major players in global Biodefense market include Emergent Biosolutions, Hytest, GSK, etc. The top 3 players occupy about 60% shares of the global market. North America, Europe and Asia are key Regions of Sales. Anthrax and Smallpox are main types, with a share about 70%. US Civilian 麻豆原创 is the main application, which holds a share about 55%.
Key Features:
The report on Biological Defense market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Biological Defense market. It may include historical data, market segmentation by Type (e.g., Anthrax, Small Pox), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Biological Defense market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Biological Defense market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Biological Defense industry. This include advancements in Biological Defense technology, Biological Defense new entrants, Biological Defense new investment, and other innovations that are shaping the future of Biological Defense.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Biological Defense market. It includes factors influencing customer ' purchasing decisions, preferences for Biological Defense product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Biological Defense market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Biological Defense market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Biological Defense market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Biological Defense industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Biological Defense market.
麻豆原创 Segmentation:
Biological Defense market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Anthrax
Small Pox
Botox
Radiation / Nuclear
Other
Segmentation by application
Military
Civilian
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SIGA Technologies
Ichor Medical Systems
Emergent BioSolutions
Elusys Therapeutics
DynPort Vaccine Company
Altimmune
Cleveland BioLabs
Bavarian Nordic
Alnylam Pharmaceuticals
Achaogen
Alexeter Technologies
ANP Technologies
PathSensors
New Horizons Diagnostics
BBI Detection

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Biological Defense 麻豆原创 Size 2019-2030
2.1.2 Biological Defense 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Biological Defense Segment by Type
2.2.1 Anthrax
2.2.2 Small Pox
2.2.3 Botox
2.2.4 Radiation / Nuclear
2.2.5 Other
2.3 Biological Defense 麻豆原创 Size by Type
2.3.1 Biological Defense 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Biological Defense 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Biological Defense Segment by Application
2.4.1 Military
2.4.2 Civilian
2.4.3 Other
2.5 Biological Defense 麻豆原创 Size by Application
2.5.1 Biological Defense 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Biological Defense 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Biological Defense 麻豆原创 Size by Player
3.1 Biological Defense 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Biological Defense Revenue by Players (2019-2024)
3.1.2 Global Biological Defense Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Biological Defense Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biological Defense by Regions
4.1 Biological Defense 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Biological Defense 麻豆原创 Size Growth (2019-2024)
4.3 APAC Biological Defense 麻豆原创 Size Growth (2019-2024)
4.4 Europe Biological Defense 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Biological Defense 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Biological Defense 麻豆原创 Size by Country (2019-2024)
5.2 Americas Biological Defense 麻豆原创 Size by Type (2019-2024)
5.3 Americas Biological Defense 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biological Defense 麻豆原创 Size by Region (2019-2024)
6.2 APAC Biological Defense 麻豆原创 Size by Type (2019-2024)
6.3 APAC Biological Defense 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biological Defense by Country (2019-2024)
7.2 Europe Biological Defense 麻豆原创 Size by Type (2019-2024)
7.3 Europe Biological Defense 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biological Defense by Region (2019-2024)
8.2 Middle East & Africa Biological Defense 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Biological Defense 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Biological Defense 麻豆原创 Forecast
10.1 Global Biological Defense Forecast by Regions (2025-2030)
10.1.1 Global Biological Defense Forecast by Regions (2025-2030)
10.1.2 Americas Biological Defense Forecast
10.1.3 APAC Biological Defense Forecast
10.1.4 Europe Biological Defense Forecast
10.1.5 Middle East & Africa Biological Defense Forecast
10.2 Americas Biological Defense Forecast by Country (2025-2030)
10.2.1 United States Biological Defense 麻豆原创 Forecast
10.2.2 Canada Biological Defense 麻豆原创 Forecast
10.2.3 Mexico Biological Defense 麻豆原创 Forecast
10.2.4 Brazil Biological Defense 麻豆原创 Forecast
10.3 APAC Biological Defense Forecast by Region (2025-2030)
10.3.1 China Biological Defense 麻豆原创 Forecast
10.3.2 Japan Biological Defense 麻豆原创 Forecast
10.3.3 Korea Biological Defense 麻豆原创 Forecast
10.3.4 Southeast Asia Biological Defense 麻豆原创 Forecast
10.3.5 India Biological Defense 麻豆原创 Forecast
10.3.6 Australia Biological Defense 麻豆原创 Forecast
10.4 Europe Biological Defense Forecast by Country (2025-2030)
10.4.1 Germany Biological Defense 麻豆原创 Forecast
10.4.2 France Biological Defense 麻豆原创 Forecast
10.4.3 UK Biological Defense 麻豆原创 Forecast
10.4.4 Italy Biological Defense 麻豆原创 Forecast
10.4.5 Russia Biological Defense 麻豆原创 Forecast
10.5 Middle East & Africa Biological Defense Forecast by Region (2025-2030)
10.5.1 Egypt Biological Defense 麻豆原创 Forecast
10.5.2 South Africa Biological Defense 麻豆原创 Forecast
10.5.3 Israel Biological Defense 麻豆原创 Forecast
10.5.4 Turkey Biological Defense 麻豆原创 Forecast
10.5.5 GCC Countries Biological Defense 麻豆原创 Forecast
10.6 Global Biological Defense Forecast by Type (2025-2030)
10.7 Global Biological Defense Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 SIGA Technologies
11.1.1 SIGA Technologies Company Information
11.1.2 SIGA Technologies Biological Defense Product Offered
11.1.3 SIGA Technologies Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 SIGA Technologies Main Business Overview
11.1.5 SIGA Technologies Latest Developments
11.2 Ichor Medical Systems
11.2.1 Ichor Medical Systems Company Information
11.2.2 Ichor Medical Systems Biological Defense Product Offered
11.2.3 Ichor Medical Systems Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Ichor Medical Systems Main Business Overview
11.2.5 Ichor Medical Systems Latest Developments
11.3 Emergent BioSolutions
11.3.1 Emergent BioSolutions Company Information
11.3.2 Emergent BioSolutions Biological Defense Product Offered
11.3.3 Emergent BioSolutions Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Emergent BioSolutions Main Business Overview
11.3.5 Emergent BioSolutions Latest Developments
11.4 Elusys Therapeutics
11.4.1 Elusys Therapeutics Company Information
11.4.2 Elusys Therapeutics Biological Defense Product Offered
11.4.3 Elusys Therapeutics Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Elusys Therapeutics Main Business Overview
11.4.5 Elusys Therapeutics Latest Developments
11.5 DynPort Vaccine Company
11.5.1 DynPort Vaccine Company Company Information
11.5.2 DynPort Vaccine Company Biological Defense Product Offered
11.5.3 DynPort Vaccine Company Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 DynPort Vaccine Company Main Business Overview
11.5.5 DynPort Vaccine Company Latest Developments
11.6 Altimmune
11.6.1 Altimmune Company Information
11.6.2 Altimmune Biological Defense Product Offered
11.6.3 Altimmune Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Altimmune Main Business Overview
11.6.5 Altimmune Latest Developments
11.7 Cleveland BioLabs
11.7.1 Cleveland BioLabs Company Information
11.7.2 Cleveland BioLabs Biological Defense Product Offered
11.7.3 Cleveland BioLabs Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Cleveland BioLabs Main Business Overview
11.7.5 Cleveland BioLabs Latest Developments
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Information
11.8.2 Bavarian Nordic Biological Defense Product Offered
11.8.3 Bavarian Nordic Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Bavarian Nordic Main Business Overview
11.8.5 Bavarian Nordic Latest Developments
11.9 Alnylam Pharmaceuticals
11.9.1 Alnylam Pharmaceuticals Company Information
11.9.2 Alnylam Pharmaceuticals Biological Defense Product Offered
11.9.3 Alnylam Pharmaceuticals Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Alnylam Pharmaceuticals Main Business Overview
11.9.5 Alnylam Pharmaceuticals Latest Developments
11.10 Achaogen
11.10.1 Achaogen Company Information
11.10.2 Achaogen Biological Defense Product Offered
11.10.3 Achaogen Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Achaogen Main Business Overview
11.10.5 Achaogen Latest Developments
11.11 Alexeter Technologies
11.11.1 Alexeter Technologies Company Information
11.11.2 Alexeter Technologies Biological Defense Product Offered
11.11.3 Alexeter Technologies Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Alexeter Technologies Main Business Overview
11.11.5 Alexeter Technologies Latest Developments
11.12 ANP Technologies
11.12.1 ANP Technologies Company Information
11.12.2 ANP Technologies Biological Defense Product Offered
11.12.3 ANP Technologies Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 ANP Technologies Main Business Overview
11.12.5 ANP Technologies Latest Developments
11.13 PathSensors
11.13.1 PathSensors Company Information
11.13.2 PathSensors Biological Defense Product Offered
11.13.3 PathSensors Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 PathSensors Main Business Overview
11.13.5 PathSensors Latest Developments
11.14 New Horizons Diagnostics
11.14.1 New Horizons Diagnostics Company Information
11.14.2 New Horizons Diagnostics Biological Defense Product Offered
11.14.3 New Horizons Diagnostics Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 New Horizons Diagnostics Main Business Overview
11.14.5 New Horizons Diagnostics Latest Developments
11.15 BBI Detection
11.15.1 BBI Detection Company Information
11.15.2 BBI Detection Biological Defense Product Offered
11.15.3 BBI Detection Biological Defense Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 BBI Detection Main Business Overview
11.15.5 BBI Detection Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.